Target intelligence / Profile preview

Taenia solium antigen (Ts Ag)

Target
Ts Ag
Molecular classification
Glycoprotein, Other
01

Overview

Taenia solium antigens are a diverse set of molecules, including proteins and glycoproteins, expressed by the pork tapeworm during its various life stages. These antigens play a pivotal role in the pathogenesis of cysticercosis and neurocysticercosis by mediating host-parasite interactions and facilitating the parasite's evasion of the host immune system (Garcia et al., 2014). In clinical diagnostics, specific antigens such as the HP10 secretory antigen and low-molecular-weight glycoproteins are targeted in enzyme-linked immunosorbent assays (ELISA) to identify active infections (Handali et al., 2010). While standard anthelmintic treatments like albendazole and praziquantel do not bind these antigens directly, they cause the death of the larvae, which results in a massive release of antigenic material into the host tissue (Nash et al., 2011). This sudden exposure often triggers a severe inflammatory response, particularly in the brain, leading to complications such as cerebral edema and seizures, which typically require management with corticosteroids (White, 2014). Furthermore, specific antigens like TSOL18 have been successfully utilized in the development of highly effective veterinary vaccines to break the transmission cycle of the parasite (Lightowlers, 2010).

Other names
Cysticercus cellulosae antigenPork tapeworm antigenNeurocysticercosis antigenTsAg
02

Mechanism of action

Anthelmintic agents like albendazole and praziquantel induce parasite death, which triggers the release of Taenia solium antigens into the host environment; corticosteroids such as dexamethasone are subsequently used to mitigate the inflammatory response elicited by these released antigens.

03

Biological functions

Immune responseOther
04

Disease associations

Infection
05

Safety considerations

Severe neuroinflammationCerebral edemaSeizure provocationJarisch-Herxheimer-like reaction
06

Interacting drugs

Albendazole

2 more in the full profile.

07

Biomarkers

HP10 secretory antigenTs8B2 glycoproteinGP50 glycoproteinAntigen B (AgB)

Beyond the preview

Go deeper on Taenia solium antigen (Ts Ag).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Taenia solium antigen (Ts Ag).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call